YU68502A - Piridazinil fenil hidrazoni korisni protiv kongestivnog srčanog udara - Google Patents

Piridazinil fenil hidrazoni korisni protiv kongestivnog srčanog udara

Info

Publication number
YU68502A
YU68502A YU68502A YUP68502A YU68502A YU 68502 A YU68502 A YU 68502A YU 68502 A YU68502 A YU 68502A YU P68502 A YUP68502 A YU P68502A YU 68502 A YU68502 A YU 68502A
Authority
YU
Yugoslavia
Prior art keywords
heart failure
congestive heart
aryl
useful against
arylalkyl
Prior art date
Application number
YU68502A
Other languages
English (en)
Inventor
Jarmo Pystynen
Aino Pippuri
Anne Luiro
Pentti Nore
Reijo Backstrom
Kari Lonnberg
Heimo Haikala
Jouko Levijoki
Petri Kaheinen
Juha Kaivola
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of YU68502A publication Critical patent/YU68502A/sh
Publication of RS50439B publication Critical patent/RS50439B/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Abstract

Terapeutski aktivna jedinjenja formule (I) gde R1 do R4 označavaju vodonik, alkil, alkenil, aril, arilalkil, karboksialkil, hidroksialkil, ili halogenalkil, ili R2 i R3 obrazuju prsten od 5-7 ugljenikovih atoma, R5 do R9 označavaju vodonik, alkil, alkenil, aril, arilalkil, acil, hidroksi, alkoksi, alkoksikarbonil, amino, acilamino, alkilamino, ariloksi, halogen, cijano, nitro, karboksi, alkilsulfonil, sulfonamido ili trifluorometil, gde svaki aril ostatak definisan gore sam po sebi ili kao deo neke druge grupe može da bude supstituisan i njihove farmaceutski prihvatljive soli i estri. Jedinjenja povećavaju kalcijumsku senzitivnost kontraktilnih proteina srčanog mišića i stoga su korisni u tretiranju kongestivnog srčanog udara.[Therapeutically active compounds of formula (I) in which R1 to R4 means hydrogen, alkyl, alkenyl, aryl, arylalkyl, carboxyalkyl, hydroxyalkyl or halogenalkyl, or R2 and R3 form a ring of 5-7 carbon atoms, R5 to R9 means hydrogen, alkyl, alkenyl, aryl, arylalkyl, acyl, hydroxy, alkoxy, alkoxycarbonyl, amino, acylamino, alkylamino, aryloxy, halogen, cyano, nitro, carboxy, alkylsulfonyl, sulfonamido or trifluoromethyl, wherein each aryl residue defined above by itself or as a part of another group may be substituted, and pharmaceutically acceptable salts and esters thereof. The compounds increase the calcium sensitivity of contractile proteins of the cardiac muscle and are thus useful in the treatment of congestive heart failure.
YUP-685/02A 2000-03-13 2001-03-12 Piridazinil fenil hidrazoni korisni protiv kogestivnog srčanog udara RS50439B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20000577A FI20000577A0 (fi) 2000-03-13 2000-03-13 Pyridatsinyylifenyylihydratsoneja

Publications (2)

Publication Number Publication Date
YU68502A true YU68502A (sh) 2005-11-28
RS50439B RS50439B (sr) 2009-12-31

Family

ID=8557913

Country Status (32)

Country Link
US (1) US6699868B2 (sh)
EP (1) EP1265871B1 (sh)
JP (1) JP2003527375A (sh)
KR (1) KR20030001379A (sh)
CN (1) CN1191241C (sh)
AR (1) AR027644A1 (sh)
AT (1) ATE317388T1 (sh)
AU (2) AU2001246577B2 (sh)
BG (1) BG65859B1 (sh)
BR (1) BR0109136A (sh)
CA (1) CA2403188A1 (sh)
CZ (1) CZ20022997A3 (sh)
DE (1) DE60117131T2 (sh)
DK (1) DK1265871T3 (sh)
EA (1) EA005574B1 (sh)
EE (1) EE200200520A (sh)
ES (1) ES2256222T3 (sh)
FI (1) FI20000577A0 (sh)
HK (1) HK1052008A1 (sh)
HR (1) HRP20020816A2 (sh)
HU (1) HUP0300177A3 (sh)
IL (2) IL151492A0 (sh)
MX (1) MXPA02008997A (sh)
NO (1) NO324172B1 (sh)
NZ (1) NZ521162A (sh)
PL (1) PL357107A1 (sh)
RS (1) RS50439B (sh)
SI (1) SI1265871T1 (sh)
SK (1) SK287163B6 (sh)
UA (1) UA74571C2 (sh)
WO (1) WO2001068611A1 (sh)
ZA (1) ZA200206917B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015228D0 (en) * 2000-06-21 2000-08-16 Portela & Ca Sa Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders
JP4561698B2 (ja) * 2002-02-19 2010-10-13 小野薬品工業株式会社 縮合ピリダジン誘導体化合物およびその化合物を有効成分として含有する薬剤
JPWO2004087641A1 (ja) * 2003-03-31 2006-06-29 第一製薬株式会社 ヒドラゾン誘導体
GB0503962D0 (en) 2005-02-25 2005-04-06 Kudos Pharm Ltd Compounds
MX2009000884A (es) 2006-07-25 2009-06-05 Cephalon Inc Derivados de piridizinona.
US20100286150A1 (en) 2007-01-17 2010-11-11 Fia Westerholm Levosimendan for use in treating chronic valvular disease
JP6123673B2 (ja) * 2011-09-27 2017-05-10 日本ゼオン株式会社 重合性化合物の製造中間体及びその製造方法
ES2684776T3 (es) * 2013-01-18 2018-10-04 Bristol-Myers Squibb Company Ftalazinonas e isoquinolinonas como inhibidores de ROCK
JPWO2019235569A1 (ja) * 2018-06-08 2021-07-08 日産化学株式会社 キナーゼ阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531658A1 (de) 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
BG65859B1 (bg) 2010-03-31
HUP0300177A3 (en) 2003-09-29
JP2003527375A (ja) 2003-09-16
MXPA02008997A (es) 2003-04-25
FI20000577A0 (fi) 2000-03-13
IL151492A0 (en) 2003-04-10
EA200200973A1 (ru) 2003-02-27
IL151492A (en) 2007-09-20
BG107175A (bg) 2003-05-30
HRP20020816A2 (en) 2004-12-31
CN1191241C (zh) 2005-03-02
CZ20022997A3 (cs) 2003-04-16
DK1265871T3 (da) 2006-06-06
HK1052008A1 (en) 2003-08-29
ATE317388T1 (de) 2006-02-15
WO2001068611A1 (en) 2001-09-20
AU4657701A (en) 2001-09-24
US20030158200A1 (en) 2003-08-21
SK287163B6 (sk) 2010-02-08
DE60117131T2 (de) 2006-10-26
EE200200520A (et) 2004-04-15
CN1418196A (zh) 2003-05-14
ZA200206917B (en) 2003-07-30
NZ521162A (en) 2003-11-28
DE60117131D1 (de) 2006-04-20
EP1265871A1 (en) 2002-12-18
EP1265871B1 (en) 2006-02-08
US6699868B2 (en) 2004-03-02
KR20030001379A (ko) 2003-01-06
AU2001246577B2 (en) 2006-08-31
CA2403188A1 (en) 2001-09-20
EA005574B1 (ru) 2005-04-28
HUP0300177A2 (hu) 2003-07-28
BR0109136A (pt) 2002-12-24
NO20024247L (no) 2002-10-25
UA74571C2 (en) 2006-01-16
SI1265871T1 (sl) 2006-06-30
NO324172B1 (no) 2007-09-03
SK12882002A3 (sk) 2003-06-03
PL357107A1 (en) 2004-07-12
ES2256222T3 (es) 2006-07-16
AR027644A1 (es) 2003-04-09
NO20024247D0 (no) 2002-09-05
RS50439B (sr) 2009-12-31

Similar Documents

Publication Publication Date Title
MY127881A (en) Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
CO5231161A1 (es) 4-aminopicolinatos y su uso como herbicidas
MY139887A (en) Tetrahydronaphthyridine derivatives and a process for preparing the same.
CA2429642A1 (en) Fused heteroaromatic glucokinase activators
PT1585739E (pt) Arilciclopropilacetamidas substitu?das como activadores da glucocinase
YU66201A (sh) Derivati amina kao inhibitori proteaze
PE20040937A1 (es) Derivados de piridazin-3(2h)-ona como inhibidores de fosfodiesterasa-4 (pde 4)
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
HUP0002843A2 (hu) Új béta-karbolin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUP0203184A2 (hu) Izoxazolkarboxamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
YU68502A (sh) Piridazinil fenil hidrazoni korisni protiv kongestivnog srčanog udara
MX9604687A (es) Procedimiento para la preparacion de derivados de imidazo-benzodiacepina.
GR3031693T3 (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
HUP0101469A2 (hu) 5-[(2-Imidazolidinilidén)-amino]-benzimidazol-származékok, előállításuk és alkalmazásuk javított metabolikus stabilitású alfa-adrenoceptor agonistákként
WO2000042995A3 (en) Use of anticonvulsant derivatives for treating transformed migraine
NO961404L (no) 4-indolylpiperazinyl-derivater
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
ES448175A1 (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2).
MXPA04003277A (es) Amida del acido 8-amino-?1,2,4?triazolo?1,5-a?piridina-6-carboxilico.
EP1144393A3 (en) Heterocyclic derivatives and their use as integrin inhibitor
NZ519126A (en) Novel IL-8 receptor antagonists
ES2010089A6 (es) Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos.
HUP0100570A2 (hu) TNF és PDE-IV inhibitor heterociklusos vegyületek N-oxidjai és ezek gyógyászati alklamazása
NZ513724A (en) Anticonvulsant derivatives useful in treating essential tremor
AU4455397A (en) Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists